Walleye Trading’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-16,800
| Closed | -$3.09M | – | 6753 |
|
|
2021
Q2 | $3.09M | Buy |
16,800
+8,100
| +93% | +$1.39M | 0.08% | 1145 |
|
|
2021
Q1 | $1.33M | Sell |
8,700
-16,000
| -65% | -$2.47M | 0.05% | 1673 |
|
|
2020
Q4 | $3.86M | Buy |
24,700
+7,300
| +42% | +$938K | 0.11% | 898 |
|
|
2020
Q3 | $1.99M | Sell |
17,400
-2,000
| -10% | -$216K | 0.16% | 1126 |
|
|
2020
Q2 | $2.18M | Sell |
19,400
-52,600
| -73% | -$5.58M | 0.13% | 1031 |
|
|
2020
Q1 | $6.46M | Buy |
72,000
+15,400
| +27% | +$1.51M | 0.41% | 307 |
|
|
2019
Q4 | $6.12M | Buy |
56,600
+41,000
| +263% | +$4.39M | 0.26% | 472 |
|
|
2019
Q3 | $1.53M | Buy |
15,600
+900
| +6% | +$101K | 0.11% | 1268 |
|
|
2019
Q2 | $1.93M | Sell |
14,700
-16,500
| -53% | -$2.13M | 0.15% | 1078 |
|
|
2019
Q1 | $4.22M | Buy |
31,200
+9,200
| +42% | +$1.14M | 0.32% | 587 |
|
|
2018
Q4 | $2.14M | Buy |
22,000
+17,200
| +358% | +$2.03M | 0.08% | 1022 |
|
|
2018
Q3 | $667K | Sell |
4,800
-1,400
| -23% | -$176K | 0.02% | 2554 |
|
|
2018
Q2 | $770K | Sell |
6,200
-10,400
| -63% | -$1.22M | 0.02% | 2383 |
|
|
2018
Q1 | $1.85M | Buy |
16,600
+14,400
| +655% | +$1.72M | 0.05% | 1273 |
|
|
2017
Q4 | $263 | Sell |
2,200
-32,000
| -94% | -$3.9M | 0.01% | 3206 |
|
|
2017
Q3 | $4.8K | Sell |
34,200
-800
| -2% | -$109K | 0.11% | 690 |
|
|
2017
Q2 | $4.26K | Buy |
35,000
+24,300
| +227% | +$2.83M | 0.14% | 681 |
|
|
2017
Q1 | $1.3K | Buy |
+10,700
| New | +$1.38M | 0.06% | 1423 |
|
|
2016
Q4 | – | Sell |
-800
| Closed | -$98K | – | 5760 |
|
|
2016
Q3 | $98K | Sell |
800
-15,100
| -95% | -$1.94M | 0.01% | 3308 |
|
|
2016
Q2 | $1.86M | Sell |
15,900
-200
| -1% | -$28.4K | 0.14% | 1049 |
|
|
2016
Q1 | $2.24M | Sell |
16,100
-19,290
| -55% | -$2.83M | 0.23% | 780 |
|
|
2015
Q4 | $6.75M | Buy |
35,390
+33,700
| +1,994% | +$5.89M | 0.38% | 290 |
|
|
2015
Q3 | $265K | Sell |
1,690
-1,610
| -49% | -$294K | 0.02% | 2100 |
|
|
2015
Q2 | $597K | Buy |
3,300
+2,900
| +725% | +$500K | 0.04% | 1516 |
|
|
2015
Q1 | $69K | Sell |
400
-13,800
| -97% | -$2.5M | 0.01% | 2904 |
|
|
2014
Q4 | $2.63M | Buy |
14,200
+14,000
| +7,000% | +$2.59M | 0.13% | 561 |
|
|
2014
Q3 | $34K | Sell |
200
-1,300
| -87% | -$213K | ﹤0.01% | 3345 |
|
|
2014
Q2 | $236 | Buy |
+1,500
| New | +$237K | 0.02% | 1871 |
|
|
2014
Q1 | – | Sell |
-400
| Closed | -$53K | – | 4204 |
|
|
2013
Q4 | $53K | Buy |
+400
| New | +$48K | ﹤0.01% | 2806 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM